<?xml version='1.0'?><!DOCTYPE Annotation PUBLIC "//GENIA//DTD GENIA ANNOTATION EVENT 2.0//EN_Modified" "../ModifiedGENIAtypes/Modified_GENIA_event_20.dtd"><Annotation annotates="http://www.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&amp;retmode=xml&amp;rettype=medline&amp;id=9045614" created="05/12/2006" creator="Junko Matsuura"><PubmedArticleSet><PubmedArticle><MedlineCitation>
<PMID>9045614</PMID>
<Article>
<ArticleTitle>
<sentence id="S1"><term id="T1" lex="immune_hyperactivation" sem="Other">Immune hyperactivation</term> of <term id="T2" lex="HIV-1-infected_T_cell" sem="Cell_natural"><term id="T3" lex="HIV-1" sem="Virus">HIV-1</term>-infected <term id="A1" sem="Cell_natural">T cells</term></term> mediated by <term id="T4" lex="Tat" sem="Protein_molecule">Tat</term> and the <term id="T5" lex="CD28_pathway" sem="Other"><term id="T6" lex="CD28" sem="Protein_molecule">CD28</term> pathway</term>.</sentence>
<event KT="Other" id="E1">
<type class="Initiation_of_viral_infection"/>
<theme idref="A1"/>
<theme idref="T3"/>
<clue>Immune hyperactivation of HIV-1-<clueType>infected</clueType> T cells mediated by Tat and the CD28 pathway.</clue>
</event>
<event KT="Other" id="E2">
<type class="Positive_regulation"/>
<theme idref="T1"/>
<cause idref="E1"/>
<clue>Immune <clueType>hyperactivation</clueType> <linkCause>of</linkCause> HIV-1-infected T cells mediated by Tat and the CD28 pathway.</clue>
</event>
<event KT="Investigation" id="E3">
<type class="Positive_regulation"/>
<theme idref="E2"/>
<cause idref="T4"/>
<clue>Immune hyperactivation of HIV-1-infected T cells <clueType>mediated</clueType> <linkCause>by</linkCause> Tat and the CD28 pathway.</clue>
</event>
<event KT="Investigation" id="E4">
<type class="Positive_regulation"/>
<theme idref="E2"/>
<cause idref="T5"/>
<clue>Immune hyperactivation of HIV-1-infected T cells <clueType>mediated</clueType> <linkCause>by</linkCause> Tat and the CD28 pathway.</clue>
</event>
</ArticleTitle>
<Abstract>
<AbstractText>
<sentence id="S2"><term id="T7" lex="human_immunodeficiency_virus-type_1_(HIV-1)_infection" sem="Other"><term id="T8" lex="human_immunodeficiency_virus-type_1" sem="Virus">Human immunodeficiency virus-type 1</term> (<term id="T9" lex="HIV-1" sem="Virus">HIV-1</term>) infection</term> is characterized by a chronic state of <term id="T10" lex="immune_hyperactivation" sem="Other">immune hyperactivation</term> in <term id="T11" lex="patient" sem="Multicellular_organism_natural">patients</term>.</sentence>
<event KT="Other" id="E5">
<type class="Initiation_of_viral_infection"/>
<theme idref="T9"/>
<clue>Human immunodeficiency virus-type 1 (HIV-1) <clueType>infection</clueType> is characterized by a chronic state of immune hyperactivation in patients.</clue>
</event>
<event KT="Fact" id="E6">
<type class="Correlation"/>
<theme idref="T10"/>
<theme idref="E5"/>
<clue>Human immunodeficiency virus-type 1 (HIV-1) infection is <clueType>characterized</clueType> <linkTheme>by</linkTheme> a chronic state of immune hyperactivation in patients.</clue>
</event>
<sentence id="S3">Infection of <term id="T12" lex="human_peripheral_blood_lymphocyte" sem="Cell_natural">human peripheral blood lymphocytes</term> with <term id="T13" lex="HIV-1" sem="Virus">HIV-1</term> in vitro resulted in increased interleukin-2 (<term id="A2" sem="Protein_molecule">IL-2</term>) secretion in response to <term id="T14" lex="T_cell_activation" sem="Other"><term id="A6" sem="Cell_natural">T cell</term> activation</term> via the <cons id="T15" lex="(AND CD3_receptor CD28_receptor)" sem="(AND Protein_molecule Protein_molecule)"><frag id="F1">CD3</frag> and <frag id="F2">CD28</frag> <frag id="F3">receptors</frag></cons>.</sentence>
<event id="E7">
<type class="Initiation_of_viral_infection"/>
<theme idref="T12"/>
<theme idref="T13"/>
<clue><clueType>Infection</clueType> <linkTheme>of</linkTheme> human peripheral blood lymphocytes <linkTheme>with</linkTheme> HIV-1 in vitro resulted in increased interleukin-2 (IL-2) secretion in response to T cell activation via the CD3 and CD28 receptors.</clue>
</event>
<event id="E8">
<type class="Physiological_process"/>
<theme idref="A6"/>
<cause idref="F1" idref1="F3"/>
<clue>Infection of human peripheral blood lymphocytes with HIV-1 in vitro resulted in increased interleukin-2 (IL-2) secretion in response to T cell <clueType>activation</clueType> <linkCause>via</linkCause> the CD3 and CD28 receptors.</clue>
</event>
<event id="E9">
<type class="Physiological_process"/>
<theme idref="A6"/>
<cause idref="F2" idref1="F3"/>
<clue>Infection of human peripheral blood lymphocytes with HIV-1 in vitro resulted in increased interleukin-2 (IL-2) secretion in response to T cell <clueType>activation</clueType> <linkCause>via</linkCause> the CD3 and CD28 receptors.</clue>
</event>
<event id="E110">
<type class="Localization"/>
<theme idref="A2"/>
<clue>Infection of human peripheral blood lymphocytes with HIV-1 in vitro resulted in increased interleukin-2 (IL-2) <clueType>secretion</clueType> in response to T cell activation via the CD3 and CD28 receptors.</clue>
</event>
<event id="E111">
<type class="Positive_regulation"/>
<theme idref="E110"/>
<cause idref="E8"/>
<clue>Infection of human peripheral blood lymphocytes with HIV-1 in vitro resulted in increased interleukin-2 (IL-2) secretion <linkCause>in response to</linkCause> T cell activation via the CD3 and CD28 receptors.</clue>
<comment>NO CLUETYPE</comment></event>
<event id="E112">
<type class="Positive_regulation"/>
<theme idref="E110"/>
<cause idref="E9"/>
<clue>Infection of human peripheral blood lymphocytes with HIV-1 in vitro resulted in increased interleukin-2 (IL-2) secretion <linkCause>in response to</linkCause> T cell activation via the CD3 and CD28 receptors.</clue>
<comment>NO CLUETYPE</comment></event>
<event id="E12">
<type class="Positive_regulation"/>
<theme idref="E111"/>
<cause idref="E7"/>
<clue>Infection of human peripheral blood lymphocytes with HIV-1 in vitro resulted in <clueType>increased</clueType> interleukin-2 (IL-2) secretion in response to T cell activation via the CD3 and CD28 receptors.</clue>
</event>
<event id="E13">
<type class="Positive_regulation"/>
<theme idref="E112"/>
<cause idref="E7"/>
<clue>Infection of human peripheral blood lymphocytes with HIV-1 in vitro resulted in <clueType>increased</clueType> interleukin-2 (IL-2) secretion in response to T cell activation via the CD3 and CD28 receptors.</clue>
</event>
<sentence id="S4">Expression of the <term id="T16" lex="HIV-1_transactivator" sem="Protein_family_or_group"><term id="T17" lex="HIV-1" sem="Virus">HIV-1</term> transactivator</term> <term id="T18" lex="Tat" sem="Protein_molecule">Tat</term> recapitulated this phenotype and was associated with increased <term id="T19" lex="IL-2_secretion" sem="Other"><term id="T20" lex="IL-2" sem="Protein_molecule">IL-2</term> secretion</term> in response to costimulation with <term id="T21" lex="CD3" sem="Protein_molecule">CD3</term> plus <term id="T22" lex="CD28" sem="Protein_molecule">CD28</term>.</sentence>
<event id="E14">
<type class="Gene_expression"/>
<theme idref="T18"/>
<clue><clueType>Expression</clueType> <linkCause>of</linkCause> the HIV-1 transactivator Tat recapitulated this phenotype and was associated with increased IL-2 secretion in response to costimulation with CD3 plus CD28.</clue>
</event>
<event KT="Other" id="E15">
<type class="Localization"/>
<theme idref="T20"/>
<clue>Expression of the HIV-1 transactivator Tat recapitulated this phenotype and was associated with increased IL-2 <clueType>secretion</clueType> in response to costimulation with CD3 plus CD28.</clue>
</event>
<event KT="Other" id="E16">
<type class="Positive_regulation"/>
<theme idref="E15"/>
<cause idref="T21"/>
<cause idref="T22"/>
<clue>Expression of the HIV-1 transactivator Tat recapitulated this phenotype and was associated with <clueType>increased</clueType> IL-2 secretion <linkCause>in response to</linkCause> costimulation with CD3 plus CD28.</clue>
</event>
<event KT="Analysis" id="E17">
<type class="Correlation"/>
<theme idref="E14"/>
<theme idref="E16"/>
<clue>Expression of the HIV-1 transactivator Tat recapitulated this phenotype and was <clueType><clueKT>associated</clueKT></clueType> <linkTheme>with</linkTheme> increased IL-2 secretion in response to costimulation with CD3 plus CD28.</clue>
</event>
<sentence id="S5"><term id="T23" lex="IL-2" sem="Protein_molecule">IL-2</term> superinduction by <term id="T24" lex="Tat" sem="Protein_molecule">Tat</term> occurred at the <term id="T25" lex="transcriptional_level" sem="Other">transcriptional level</term>, was mediated by the <term id="T26" lex="CD28-responsive_element" sem="DNA_domain_or_region"><term id="T27" lex="CD28" sem="Protein_molecule">CD28</term>-responsive element</term> in the <term id="T28" lex="IL-2_promoter" sem="DNA_domain_or_region"><term id="T29" lex="IL-2" sem="Protein_molecule">IL-2</term> promoter</term>, and was exclusively dependent on the <term id="A7" sem="Protein_domain_or_region"><term id="T30" lex="29_amino_acids" sem="Protein_domain_or_region">29 amino acids</term> encoded by the <term id="T31" lex="second_exon_of_Tat" sem="DNA_domain_or_region">second exon of <term id="T32" lex="Tat" sem="Protein_molecule">Tat</term></term></term>.</sentence>
<event id="E18">
<type class="Positive_regulation"/>
<theme idref="T23"/>
<cause idref="T24"/>
<clue>IL-2 <clueType>superinduction</clueType> <linkCause>by</linkCause> Tat occurred at the transcriptional level, was mediated by the CD28-responsive element in the IL-2 promoter, and was exclusively dependent on the 29 amino acids encoded by the second exon of Tat.</clue>
</event>
<event id="E19">
<type class="Positive_regulation"/>
<theme idref="E18"/>
<cause idref="T26"/>
<clue>IL-2 superinduction by Tat occurred at the transcriptional level, was <clueType>mediated</clueType> <linkCause>by</linkCause> the CD28-responsive element in the IL-2 promoter, and was exclusively dependent on the 29 amino acids encoded by the second exon of Tat.</clue>
</event>
<event id="E20">
<type class="Positive_regulation"/>
<theme idref="E18"/>
<cause idref="A7"/>
<clue>IL-2 superinduction by Tat occurred at the transcriptional level, was mediated by the CD28-responsive element in the IL-2 promoter, and was exclusively <clueType>dependent</clueType> <linkCause>on</linkCause> the 29 amino acids encoded by the second exon of Tat.</clue>
<comment>TPS: A7</comment></event>
</AbstractText>
</Abstract></Article></MedlineCitation></PubmedArticle></PubmedArticleSet></Annotation>
